Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study. - Wikidata - awgldk - TriplyDB

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

http://www.wikidata.org/entity/Q46516794

about

A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma.A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma.Novel systemic therapy against malignant pleural mesothelioma.Efficacy of a novel mucolytic agent on pseudomyxoma peritonei mucin, with potential for treatment through peritoneal catheters.Malignant pleural mesothelioma: an update on diagnosis and treatment options.Chemotherapy and targeted therapies for unresectable malignant mesothelioma The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma.First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial.Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients.Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: a phase II study of the Southwest Oncology Group (SWOG 9810)Malignant pleural mesothelioma: current treatments and emerging drugs.Surgery for malignant pleural mesothelioma.Management of malignant pleural mesothelioma-The European experience.Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study.Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.Current chemotherapy strategies in malignant pleural mesothelioma

P2860

Q33414357-66E856D4-E4CC-4A69-A572-4741453FC575 Q33812537-39BA5D98-C2E6-42AE-964A-5234B6E0ADFD Q33890499-0D0FCB72-5BA9-46D2-8DBC-86AE607CD772 Q34178486-66FFA0F7-B037-4673-8050-8F97D224A7E3 Q34513958-E2E89249-F0CA-4BF8-B598-2A0629C71203 Q35141369-5E84B194-FE0E-48C0-BCF6-F57DBF05AFEA Q35686558-BED84534-086C-4744-B3A8-AE7F6646AF6A Q35832320-04F460F1-0F94-425C-90AB-26A8647358A4 Q36097706-766987C0-8B66-4AEE-A7A6-79A624C6B8E6 Q36322368-F813701E-2A44-433A-B436-9B8923EC6C75 Q37243005-5F53E6BB-6EE0-4627-A53E-E4D5FFADF839 Q37529848-F23C95F3-3924-4B5D-BA8D-4961019AD06F Q37762833-CC10C5E5-5B6B-4627-8663-F3AE2C89F69F Q38215513-1345F2A5-F94A-4DAE-BDF3-DBB77399CD58 Q43466291-0B103FAD-BB81-4E7F-A29E-80176E63638C Q50665635-28C706F7-9E37-4D3D-AF76-43E312C50CF9 Q52672893-0E6E33C9-5DE4-47E1-87B5-DA114C46A65D Q59132464-2EE52033-8D2C-4073-8CA3-A8525A17F883

P2860

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

http://www.wikidata.org/entity/Q46516794

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

@en

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

@nl

type

label

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

@en

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

@nl

prefLabel

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

@en

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

@nl

P1433

Q46516794-714CB332-936B-4EBF-A7F3-89E5C543B1EE

P1476

Q46516794-1A7C6F29-DDBD-4648-A4CC-8D299ADC03AD

P2093

Q46516794-18F296DB-C594-4F00-93DA-E0DB8BD7D221

Q46516794-19E158AD-37BF-46F6-A617-53032A7A67BB

Q46516794-25A71BB2-FCE0-4348-9485-D9C0D5DD874C

Q46516794-3E5E6745-43BB-4812-A3AC-4BA0BDE33785

Q46516794-63FAF7B8-C38F-4087-96DB-DFB30D5703EA

Q46516794-711166CC-2E33-4740-A2F0-DCF401FB5A7A

Q46516794-7DAD9930-8018-4E98-A26A-30DE9FD9A8D6

Q46516794-A93D74DA-A3C4-4E91-A293-57B5B3C92E2B

P304

Q46516794-B18EE419-ABAF-44BB-BC9B-3F54BAA19792

P31

Q46516794-E7BF9EEA-0AC0-43CF-B791-64C9B0427455

P356

Q46516794-519A8073-A2C3-4F1F-A85A-5F800334937B

P433

Q46516794-AD74021D-3574-4A76-B4F1-D7C758E205DF

P478

Q46516794-17FFAC50-472A-48B3-B69A-FF7F8509AA99

P577

Q46516794-B84DE139-B137-4578-B915-A70F344708AC

P698

Q46516794-3CB1ECDC-BB09-414F-B0AE-8B4107E95FCE

P356

01.COC.0000144852.75613.56

P1433

American Journal of Clinical Oncology

P1476

Cisplatin and gemcitabine in malignant pleural mesothelioma: a phase II study.

@en

P2093

Alberto Muzio

http://www.w3.org/2001/XMLSchema#string

Bruno Castagneto

http://www.w3.org/2001/XMLSchema#string

Diego Dongiovanni

http://www.w3.org/2001/XMLSchema#string

G Sinaccio

http://www.w3.org/2001/XMLSchema#string

Gianmauro Numico

http://www.w3.org/2001/XMLSchema#string

Mario Botta

http://www.w3.org/2001/XMLSchema#string

Sergio Bretti

http://www.w3.org/2001/XMLSchema#string

Silvia Zai

http://www.w3.org/2001/XMLSchema#string

P304

223-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.COC.0000144852.75613.56

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15923792

http://www.w3.org/2001/XMLSchema#string